The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Custom Recombinant Antibody Conversion Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fab and scFv Antibody Fragment Production
1.2.3 Chimeric Antibody Production
1.2.4 Bispecific Antibody Production
1.2.5 Antibody Labeling and Conjugation
1.3 Market by Application
1.3.1 Global Custom Recombinant Antibody Conversion Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Research and Development
1.3.3 Diagnostics
1.3.4 Therapeutics
1.3.5 Biomanufacturing
1.3.6 Agriculture and Food
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Custom Recombinant Antibody Conversion Service Market Perspective (2018-2029)
2.2 Custom Recombinant Antibody Conversion Service Growth Trends by Region
2.2.1 Global Custom Recombinant Antibody Conversion Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Custom Recombinant Antibody Conversion Service Historic Market Size by Region (2018-2023)
2.2.3 Custom Recombinant Antibody Conversion Service Forecasted Market Size by Region (2024-2029)
2.3 Custom Recombinant Antibody Conversion Service Market Dynamics
2.3.1 Custom Recombinant Antibody Conversion Service Industry Trends
2.3.2 Custom Recombinant Antibody Conversion Service Market Drivers
2.3.3 Custom Recombinant Antibody Conversion Service Market Challenges
2.3.4 Custom Recombinant Antibody Conversion Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Custom Recombinant Antibody Conversion Service Players by Revenue
3.1.1 Global Top Custom Recombinant Antibody Conversion Service Players by Revenue (2018-2023)
3.1.2 Global Custom Recombinant Antibody Conversion Service Revenue Market Share by Players (2018-2023)
3.2 Global Custom Recombinant Antibody Conversion Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Custom Recombinant Antibody Conversion Service Revenue
3.4 Global Custom Recombinant Antibody Conversion Service Market Concentration Ratio
3.4.1 Global Custom Recombinant Antibody Conversion Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Custom Recombinant Antibody Conversion Service Revenue in 2022
3.5 Custom Recombinant Antibody Conversion Service Key Players Head office and Area Served
3.6 Key Players Custom Recombinant Antibody Conversion Service Product Solution and Service
3.7 Date of Enter into Custom Recombinant Antibody Conversion Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Custom Recombinant Antibody Conversion Service Breakdown Data by Type
4.1 Global Custom Recombinant Antibody Conversion Service Historic Market Size by Type (2018-2023)
4.2 Global Custom Recombinant Antibody Conversion Service Forecasted Market Size by Type (2024-2029)
5 Custom Recombinant Antibody Conversion Service Breakdown Data by Application
5.1 Global Custom Recombinant Antibody Conversion Service Historic Market Size by Application (2018-2023)
5.2 Global Custom Recombinant Antibody Conversion Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
6.2 North America Custom Recombinant Antibody Conversion Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Custom Recombinant Antibody Conversion Service Market Size by Country (2018-2023)
6.4 North America Custom Recombinant Antibody Conversion Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
7.2 Europe Custom Recombinant Antibody Conversion Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Custom Recombinant Antibody Conversion Service Market Size by Country (2018-2023)
7.4 Europe Custom Recombinant Antibody Conversion Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
8.2 Asia-Pacific Custom Recombinant Antibody Conversion Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Custom Recombinant Antibody Conversion Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
9.2 Latin America Custom Recombinant Antibody Conversion Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Custom Recombinant Antibody Conversion Service Market Size by Country (2018-2023)
9.4 Latin America Custom Recombinant Antibody Conversion Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size (2018-2029)
10.2 Middle East & Africa Custom Recombinant Antibody Conversion Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Custom Recombinant Antibody Conversion Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Detail
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs Custom Recombinant Antibody Conversion Service Introduction
11.1.4 Creative Biolabs Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.1.5 Creative Biolabs Recent Development
11.2 Abnova Corporation
11.2.1 Abnova Corporation Company Detail
11.2.2 Abnova Corporation Business Overview
11.2.3 Abnova Corporation Custom Recombinant Antibody Conversion Service Introduction
11.2.4 Abnova Corporation Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.2.5 Abnova Corporation Recent Development
11.3 GenScript Biotech Corporation
11.3.1 GenScript Biotech Corporation Company Detail
11.3.2 GenScript Biotech Corporation Business Overview
11.3.3 GenScript Biotech Corporation Custom Recombinant Antibody Conversion Service Introduction
11.3.4 GenScript Biotech Corporation Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.3.5 GenScript Biotech Corporation Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Custom Recombinant Antibody Conversion Service Introduction
11.4.4 Bio-Rad Laboratories Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Custom Recombinant Antibody Conversion Service Introduction
11.5.4 Thermo Fisher Scientific Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Covance Inc.
11.6.1 Covance Inc. Company Detail
11.6.2 Covance Inc. Business Overview
11.6.3 Covance Inc. Custom Recombinant Antibody Conversion Service Introduction
11.6.4 Covance Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.6.5 Covance Inc. Recent Development
11.7 Rockland Immunochemicals Inc.
11.7.1 Rockland Immunochemicals Inc. Company Detail
11.7.2 Rockland Immunochemicals Inc. Business Overview
11.7.3 Rockland Immunochemicals Inc. Custom Recombinant Antibody Conversion Service Introduction
11.7.4 Rockland Immunochemicals Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.7.5 Rockland Immunochemicals Inc. Recent Development
11.8 LakePharma Inc.
11.8.1 LakePharma Inc. Company Detail
11.8.2 LakePharma Inc. Business Overview
11.8.3 LakePharma Inc. Custom Recombinant Antibody Conversion Service Introduction
11.8.4 LakePharma Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.8.5 LakePharma Inc. Recent Development
11.9 ProteoGenix
11.9.1 ProteoGenix Company Detail
11.9.2 ProteoGenix Business Overview
11.9.3 ProteoGenix Custom Recombinant Antibody Conversion Service Introduction
11.9.4 ProteoGenix Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.9.5 ProteoGenix Recent Development
11.10 ProMab Biotechnologies Inc.
11.10.1 ProMab Biotechnologies Inc. Company Detail
11.10.2 ProMab Biotechnologies Inc. Business Overview
11.10.3 ProMab Biotechnologies Inc. Custom Recombinant Antibody Conversion Service Introduction
11.10.4 ProMab Biotechnologies Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.10.5 ProMab Biotechnologies Inc. Recent Development
11.11 Sino Biological Inc.
11.11.1 Sino Biological Inc. Company Detail
11.11.2 Sino Biological Inc. Business Overview
11.11.3 Sino Biological Inc. Custom Recombinant Antibody Conversion Service Introduction
11.11.4 Sino Biological Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.11.5 Sino Biological Inc. Recent Development
11.12 BOC Sciences
11.12.1 BOC Sciences Company Detail
11.12.2 BOC Sciences Business Overview
11.12.3 BOC Sciences Custom Recombinant Antibody Conversion Service Introduction
11.12.4 BOC Sciences Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.12.5 BOC Sciences Recent Development
11.13 Antitope Limited
11.13.1 Antitope Limited Company Detail
11.13.2 Antitope Limited Business Overview
11.13.3 Antitope Limited Custom Recombinant Antibody Conversion Service Introduction
11.13.4 Antitope Limited Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.13.5 Antitope Limited Recent Development
11.14 Absolute Antibody Ltd.
11.14.1 Absolute Antibody Ltd. Company Detail
11.14.2 Absolute Antibody Ltd. Business Overview
11.14.3 Absolute Antibody Ltd. Custom Recombinant Antibody Conversion Service Introduction
11.14.4 Absolute Antibody Ltd. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.14.5 Absolute Antibody Ltd. Recent Development
11.15 Genscript USA Inc.
11.15.1 Genscript USA Inc. Company Detail
11.15.2 Genscript USA Inc. Business Overview
11.15.3 Genscript USA Inc. Custom Recombinant Antibody Conversion Service Introduction
11.15.4 Genscript USA Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.15.5 Genscript USA Inc. Recent Development
11.16 OriGene Technologies Inc.
11.16.1 OriGene Technologies Inc. Company Detail
11.16.2 OriGene Technologies Inc. Business Overview
11.16.3 OriGene Technologies Inc. Custom Recombinant Antibody Conversion Service Introduction
11.16.4 OriGene Technologies Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.16.5 OriGene Technologies Inc. Recent Development
11.17 Fitzgerald Industries International
11.17.1 Fitzgerald Industries International Company Detail
11.17.2 Fitzgerald Industries International Business Overview
11.17.3 Fitzgerald Industries International Custom Recombinant Antibody Conversion Service Introduction
11.17.4 Fitzgerald Industries International Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.17.5 Fitzgerald Industries International Recent Development
11.18 Novus Biologicals LLC
11.18.1 Novus Biologicals LLC Company Detail
11.18.2 Novus Biologicals LLC Business Overview
11.18.3 Novus Biologicals LLC Custom Recombinant Antibody Conversion Service Introduction
11.18.4 Novus Biologicals LLC Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.18.5 Novus Biologicals LLC Recent Development
11.19 BioLegend Inc.
11.19.1 BioLegend Inc. Company Detail
11.19.2 BioLegend Inc. Business Overview
11.19.3 BioLegend Inc. Custom Recombinant Antibody Conversion Service Introduction
11.19.4 BioLegend Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.19.5 BioLegend Inc. Recent Development
11.20 RayBiotech Inc.
11.20.1 RayBiotech Inc. Company Detail
11.20.2 RayBiotech Inc. Business Overview
11.20.3 RayBiotech Inc. Custom Recombinant Antibody Conversion Service Introduction
11.20.4 RayBiotech Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.20.5 RayBiotech Inc. Recent Development
11.21 Proteintech Group Inc.
11.21.1 Proteintech Group Inc. Company Detail
11.21.2 Proteintech Group Inc. Business Overview
11.21.3 Proteintech Group Inc. Custom Recombinant Antibody Conversion Service Introduction
11.21.4 Proteintech Group Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.21.5 Proteintech Group Inc. Recent Development
11.22 ACROBiosystems
11.22.1 ACROBiosystems Company Detail
11.22.2 ACROBiosystems Business Overview
11.22.3 ACROBiosystems Custom Recombinant Antibody Conversion Service Introduction
11.22.4 ACROBiosystems Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.22.5 ACROBiosystems Recent Development
11.23 Atlas Antibodies AB
11.23.1 Atlas Antibodies AB Company Detail
11.23.2 Atlas Antibodies AB Business Overview
11.23.3 Atlas Antibodies AB Custom Recombinant Antibody Conversion Service Introduction
11.23.4 Atlas Antibodies AB Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.23.5 Atlas Antibodies AB Recent Development
11.24 Agilent Technologies
11.24.1 Agilent Technologies Company Detail
11.24.2 Agilent Technologies Business Overview
11.24.3 Agilent Technologies Custom Recombinant Antibody Conversion Service Introduction
11.24.4 Agilent Technologies Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.24.5 Agilent Technologies Recent Development
11.25 Molecular Innovations Inc.
11.25.1 Molecular Innovations Inc. Company Detail
11.25.2 Molecular Innovations Inc. Business Overview
11.25.3 Molecular Innovations Inc. Custom Recombinant Antibody Conversion Service Introduction
11.25.4 Molecular Innovations Inc. Revenue in Custom Recombinant Antibody Conversion Service Business (2018-2023)
11.25.5 Molecular Innovations Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details